SPRO

Spero Therapeutics News

Company Name Stock Ticker Symbol Market Type
Spero Therapeutics Inc SPRO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.04 -1.93% 2.03 11:25:15
Open Price Low Price High Price Close Price Prev Close
2.05 1.96 2.0797 2.07
more quote information »

Recent News

Date Time Source Heading
10/03/202208:05GLOBESpero Therapeutics to Host Virtual R&D Event on..
9/26/202215:32EDGARStatement of Changes in Beneficial Ownership (4)
9/26/202206:25TRMNH.C. Wainwright Reaffirms Their Buy Rating on Spero..
9/23/202208:35TRMNPositive Report for Spero Therapeutics (SPRO) from Evercore..
9/22/202210:20APSMicro Cap Up Over +100% In Premarket
9/22/202208:01EDGARCurrent Report Filing (8-k)
9/22/202206:57TRMNSpero Therapeutics (NASDAQ:SPRO) Soars on Major GSK Deal
9/22/202206:30DJNSpero Therapeutics Shares Take Flight Premarket on GSK Pact
9/22/202202:00GLOBEGSK and Spero Therapeutics Announce Exclusive License..
9/19/202217:45EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202217:45EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202217:44EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202217:44EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202217:41EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202217:40EDGARStatement of Changes in Beneficial Ownership (4)
9/19/202217:40EDGARStatement of Changes in Beneficial Ownership (4)
9/15/202216:05GLOBESpero Therapeutics Announces Appointment of Kamal Hamed, MD,..
9/07/202208:05GLOBESpero Therapeutics to Present at Upcoming Investor..
9/07/202207:50TRMNAnalysts Are Bullish on Top Healthcare Stocks: Spero..
9/06/202211:45DJNSpero Therapeutics Shares Up 38% On FDA's Feedback of..
9/06/202208:16EDGARCurrent Report Filing (8-k)
9/06/202208:05GLOBESpero Therapeutics Provides Tebipenem HBr Program Update..
8/15/202206:35TRMNH.C. Wainwright Reaffirms Their Buy Rating on Spero..
8/10/202216:10EDGARCurrent Report Filing (8-k)
8/10/202216:05EDGARQuarterly Report (10-q)
8/10/202216:05GLOBESpero Therapeutics Announces Second Quarter 2022 Operating..
8/09/202208:05GLOBESpero Therapeutics to Provide Business Update and Report..
8/05/202216:09EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/22/202205:45PRNUSSPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero..
7/20/202205:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
7/15/202205:45PRNUSSPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero..
7/13/202205:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
7/08/202217:01EDGARStatement of Ownership (sc 13g)
7/08/202206:25TRMNH.C. Wainwright Reiterates Their Buy Rating on Spero..
7/08/202205:45PRNUSSPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero..
7/06/202205:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
7/01/202216:07EDGARCurrent Report Filing (8-k)
7/01/202205:45PRNUSSPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero..
6/29/202212:30PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
6/27/202216:12EDGARCurrent Report Filing (8-k)
6/27/202216:05GLOBESpero Therapeutics Receives Complete Response Letter from..
6/24/202205:45PRNUSSPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero..
6/22/202205:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
6/17/202205:45PRNUSSPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero..
6/15/202205:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
6/10/202205:45PRNUSSPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero..
6/08/202205:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
6/07/202216:02EDGARCurrent Report Filing (8-k)
6/03/202205:45PRNUSSPRO SHAREHOLDER ALERT: Jakubowitz Law Reminds Spero..
5/23/202206:27TRMNH.C. Wainwright Thinks Spero Therapeutics’ Stock is Going to..
Your Recent History
NASDAQ
SPRO
Spero Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221007 15:40:16